The effect of laser therapy on the orofacial pai

Phase 2

• Conditions: Condition 1: Trigeminal Neuralgia. Condition 2: Myofacial Pain Dysfunction Syndroms. Condition 3: Atypical Facial Pain.; Diseases of the nervous system,disorders of 5th cranial nerve; Diseases of the musculoskeletal system and connective tissue, Other disorders of muscle; Nerve, nerve root and plexus disorders, disorders of 5th cranial nerve

• Registration Number: IRCT201201018585N1
• Lead Sponsor: Vice chancellor for research, Shiraz University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 22 February 2018

Recruitment & Eligibility

• Status: Complete
• Sex: All
• Target Recruitment: 60

Inclusion Criteria

Having the criteria of each of the pains including Trigeminel Neuralgia, Atypical Facial Pain and Myofacial Pain Dysfunction Syndrome? The patients who have not a good response to routine drug therapy?
Exclusion criteria: the patients who have a good response to previous drug therapy? The pregnant women

Exclusion Criteria

Not provided

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
The amount of pain. Timepoint: Before and after intervention and 2-4 months after intervention. Method of measurement: Visual Analogue Scale.

Secondary Outcome Measures

Name	Time	Method
The metabolit of serotoninlike 5-hydroxy indole acetic acid (5-HIAA). Timepoint: Before ,after,2-4 month after intervention. Method of measurement: 24-hour urine.